Network toxicology and bioinformatics reveal potential molecular links between cadmium exposure and pancreatic cancer

BACKGROUND: Environmental cadmium (Cd) pollution poses a severe threat to human health due to its strong bioaccumulation and high carcinogenicity. Although Cd exposure has been linked to various cancers, its specific role in pancreatic cancer (PC) remains unclear. This study aimed to explore the molecular mechanisms underlying Cd-associated PC and identify potential diagnostic and therapeutic targets. METHODS: Transcriptomic data of PC were obtained from the GEO database to screen differentially expressed genes (DEGs), which were then intersected with Cd-related genes retrieved from the Comparative Toxicogenomics Database (CTD). Functional enrichment analyses, including GO and KEGG, were conducted to identify key biological processes and pathways. Multiple machine learning algorithms were used to construct a diagnostic model and identify hub genes. Furthermore, molecular docking and molecular dynamics simulations were performed to evaluate drug-target interactions, and in vitro experiments were used to validate the effects of Cd exposure on PC cell proliferation and invasiveness. RESULTS: A total of five key genes-FN1, COL5A1, AHR, COL3A1, and TIMP1-were identified as core regulators of Cd-associated PC. Functional analyses indicated that Cd primarily affects the extracellular matrix (ECM) metabolic and collagen remodeling pathways. Experimental results confirmed that Cd exposure significantly enhanced the proliferation and invasiveness of PC cells. Molecular docking and dynamics simulations revealed that the EGFR inhibitor dacomitinib exhibited favorable predicted binding affinity to FN1, suggesting its potential as a therapeutic agent. CONCLUSIONS: This study reveals that Cd may promote the malignant progression of PC by regulating ECM remodeling through key genes such as FN1. Dacomitinib shows promise as an FN1-associated therapy, offering new insights for the precise prevention and treatment of Cd-associated PC.

Authors

Institutions

Publication Details

Journal
BMC Pharmacology and Toxicology
Published
2026-05-29
DOI
https://doi.org/10.1186/s40360-026-01156-6
Primary Topic
Heavy Metal Exposure and Toxicity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Network toxicology and bioinformatics reveal potential molecular links between cadmium exposure and pancreatic cancer

Y Zhang, Xing Wan, J N Li, Shuyuan Liu et al.
BMC Pharmacology and Toxicology
Heavy Metal Exposure and Toxicity
article

Network toxicology and bioinformatics reveal potential molecular links between cadmium exposure and pancreatic cancer

Y Zhang, Xing Wan, J N Li, Shuyuan Liu, Dong Shang, Xinyan Lu, Desheng Li, Qingkai Zhang, Jingyuan Ma
article en

Abstract

BACKGROUND: Environmental cadmium (Cd) pollution poses a severe threat to human health due to its strong bioaccumulation and high carcinogenicity. Although Cd exposure has been linked to various cancers, its specific role in pancreatic cancer (PC) remains unclear. This study aimed to explore the molecular mechanisms underlying Cd-associated PC and identify potential diagnostic and therapeutic targets. METHODS: Transcriptomic data of PC were obtained from the GEO database to screen differentially expressed genes (DEGs), which were then intersected with Cd-related genes retrieved from the Comparative Toxicogenomics Database (CTD). Functional enrichment analyses, including GO and KEGG, were conducted to identify key biological processes and pathways. Multiple machine learning algorithms were used to construct a diagnostic model and identify hub genes. Furthermore, molecular docking and molecular dynamics simulations were performed to evaluate drug-target interactions, and in vitro experiments were used to validate the effects of Cd exposure on PC cell proliferation and invasiveness. RESULTS: A total of five key genes-FN1, COL5A1, AHR, COL3A1, and TIMP1-were identified as core regulators of Cd-associated PC. Functional analyses indicated that Cd primarily affects the extracellular matrix (ECM) metabolic and collagen remodeling pathways. Experimental results confirmed that Cd exposure significantly enhanced the proliferation and invasiveness of PC cells. Molecular docking and dynamics simulations revealed that the EGFR inhibitor dacomitinib exhibited favorable predicted binding affinity to FN1, suggesting its potential as a therapeutic agent. CONCLUSIONS: This study reveals that Cd may promote the malignant progression of PC by regulating ECM remodeling through key genes such as FN1. Dacomitinib shows promise as an FN1-associated therapy, offering new insights for the precise prevention and treatment of Cd-associated PC.

BMC Pharmacology and Toxicology
Dalian Medical University (CN), Liaoning University of Traditional Chinese Medicine (CN), First Affiliated Hospital of Dalian Medical University (CN)
Openalex Percentile: Top 6%
Heavy Metal Exposure and Toxicity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.